Tech Company Financing Transactions

NantCell Funding Round

On 12/29/2018, NantCell landed $30 million in funding from private investors.

Transaction Overview

Company Name
Announced On
12/29/2018
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 1 investor participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2040 E Mariposa Ave.
El Segundo, CA 90245
USA
Email Address
Overview
NantCell, an entity controlled by Dr. Patrick Soon-Shiong, is an immuno-oncology company focused on the discovery of innovative antibody, T cell and NK cell based treatments by developing molecularly targeted therapeutics, based on the proteomic profile of the patient's tumor, independent of the cancer's anatomical type.
Profile
NantCell LinkedIn Company Profile
Social Media
NantCell Company Twitter Account
Company News
NantCell News
Facebook
NantCell on Facebook
YouTube
NantCell on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Patrick Soon-Shiong
  Patrick Soon-Shiong LinkedIn Profile  Patrick Soon-Shiong Twitter Account  Patrick Soon-Shiong News  Patrick Soon-Shiong on Facebook
Chief Financial Officer
Robert Petrou
  Robert Petrou LinkedIn Profile  Robert Petrou Twitter Account  Robert Petrou News  Robert Petrou on Facebook
Chief Medical Officer
Sandeep Reddy
  Sandeep Reddy LinkedIn Profile  Sandeep Reddy Twitter Account  Sandeep Reddy News  Sandeep Reddy on Facebook
Chief Operating Officer
Ronald Louks
  Ronald Louks LinkedIn Profile  Ronald Louks Twitter Account  Ronald Louks News  Ronald Louks on Facebook
VP - Bus. Development
Nikko Khazana
  Nikko Khazana LinkedIn Profile  Nikko Khazana Twitter Account  Nikko Khazana News  Nikko Khazana on Facebook
VP - Client Services
Keith Krebs
  Keith Krebs LinkedIn Profile  Keith Krebs Twitter Account  Keith Krebs News  Keith Krebs on Facebook
VP - General Counsel
Brandon Villery
  Brandon Villery LinkedIn Profile  Brandon Villery Twitter Account  Brandon Villery News  Brandon Villery on Facebook
VP - Human Resources
Maureen Becker
  Maureen Becker LinkedIn Profile  Maureen Becker Twitter Account  Maureen Becker News  Maureen Becker on Facebook
VP - Marketing
Charles Hunt
  Charles Hunt LinkedIn Profile  Charles Hunt Twitter Account  Charles Hunt News  Charles Hunt on Facebook
VP - Product Management
Chris House
  Chris House LinkedIn Profile  Chris House Twitter Account  Chris House News  Chris House on Facebook
VP - Sales
Mark Mozley
  Mark Mozley LinkedIn Profile  Mark Mozley Twitter Account  Mark Mozley News  Mark Mozley on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/29/2018: NuoDB venture capital transaction
Next: 12/29/2018: iota Biosciences venture capital transaction

 

Share this article

 


About Our VC Transactions Data

Our team works diligently to record every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary